An important FDA-approved Drug Alert for INVIRASE affecting Cardiology, Infectious Disease, Internal Medicine, Pediatrics, Nurse Practitioners, and Pharmacies was published on February 28, 2013. This PDR® Drug Alert was delivered electronically to all Arkansas Medical Society members within this specialty who are registered with PDR® Network.
To ensure that you immediately receive electronic PDR® Drug Alerts, please encourage them to register at http://www.arkmed.pdr.net.
ArkMed members not registered to receive PDR Drug Alerts may view this information here.
PDR Drug Alerts offer immediate, electronic delivery of FDA-approved, specialty-specific Drug Alerts, and safety information for ArkMed members, and are aggregated on PDR.net for convenient review. As an added benefit, your members may also earn continuing medical education (CME) credit for Drug Alerts and FDA-approved product labeling.